New tools for the treatment of type 1 diabetes in children

Enrique Palomo Atance^a, Ana Belén Suárez Lascano^b, Laura Acero García de la Santa^c

^aServicio de Endocrinología Pediátrica. Hospital General Universitario de Ciudad Real. Ciudad Real. España.
^bAlumna del Máster de Endocrinología Pediátrica. Servicio de Endocrinología Pediátrica. Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. España.
^cMIR-Pediatría. Hospital General Universitario de Ciudad Real. Ciudad Real. España.

Correspondence: E Palomo. E-mail: palomo.enrique@gmail.com

Reference of this article: Palomo Atance E, Suárez Lascano AB, Acero García de la Santa L. New tools for the treatment of type 1 diabetes in children . Rev Pediatr Aten Primaria. 2024;26:321-7. https://doi.org/10.60147/40a65e5a

Published in Internet: 24-09-2024 - Visits: 419

Abstract

In recent years, new resorces have been appearing in order to improve glycaemic control in patients with type 1 diabetes. These include new insulin analogues, glucose monitoring, smart insulin pens and hybrid close-loop systems. So, in these patients the percentage of time in range has increased, the episodes of hypoglycaemia or hyperglycaemia have decreased, and quality of life has improved. Finally, in the following years biological drugs such as teplizumab will be incorporated, which will be the first etiological treatment for type 1 diabetes.

Keywords

● Advanced hybrid closed-loop systems ● Continuous glucose monitoring ● Teplizumab ● Type 1 diabetes

Comments

This article has no comments yet.